Location: Bonnet Creek XI

Session 1: 8:30 a.m. - 12:00 p.m.

Moderators:
Johann Urschitz, PhD
Thomas Jansson, MD, PhD

Utero-Placental Gene-Targeting In Vivo: From Mice to Humans>

Lentiviral Vector-Mediated Placenta-Specific Gene Manipulation in Mice
Masahito Ikawa, PhD
Osaka University

9:30 a.m. - 10:00 a.m.

Break

10:00 a.m. - 10:30 a.m.

PiggyBac Transposase-Mediated Gene Modulation in the Placenta
Johann Urschitz, PhD
University of Hawaii

10:30 a.m. - 11:00 p.m.

Nano-Particle Mediated Placental IGF-1 Therapy in IUGR
Helen N. Jones, PhD
Cincinnati Children's Hospital Medical Center

11:00 a.m. - 12:00 p.m.

Uterine Artery Adenovirus-Mediated Delivery of VEGF to Improve Fetal Growth in IUGR
Anna David, PhD
University College London

12:00 p.m. - 1:30 p.m.

Lunch

Session 2: 1:30 p.m. - 4:30 p.m.

Moderators:
Anna Euser, MD, PhD
Thaddeus G. Golos, PhD

Zika and the Placenta

1:30 p.m. - 2:15 p.m.

Mechanisms of Antiviral Defense at the Maternal-Fetal Interface
Carolyn Coyne, PhD
University of Pittsburgh

2:15 p.m. - 3:00 p.m.

Zika GO: Tracking ZIKV in the Placenta
Indira Mysorekar, PhD
Washington University

3:00 p.m. - 3:30 p.m.

Zika Virus Infects Human Placental Macrophages
Rana Chakraborty, MD
Emory University

3:30 p.m. - 4:00 p.m.

Break

4:00 p.m. - 4:30 p.m.

Transplacental Innate Immune Defense and Transmission of ZIKV
Jennifer Stencel-Baerenwald, PhD
University of Washington

Session 3: 4:30 p.m. - 5:00 p.m.

Moderator: Leslie Myatt, PhD, FRCOG

The Human Placental Project: An Update

4:30 p.m. - 5:00 p.m.

The Human Placenta Project: Progress and Future Directions
David Weinberg, PhD
NICHD